Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samra Turajlic

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Nature Communications|July 15, 2024
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Culliford, Samuel E D Lawrence, Charlie Mills, et al.
European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.
Clinical Genitourinary Cancer|December 28, 2020
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a CureBrian Rini, E Jason Abel, Laurence Albiges, et al.
European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.
European Urology|July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursHolger Moch, Mahul B Amin, Daniel M Berney, et al.
Cancer Discovery|May 2, 2025
MANIFEST: Multiomic Platform for Cancer ImmunotherapyKok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie, et al.
Nature Genetics|July 5, 2024
Saturation genome editing maps the functional spectrum of pathogenic VHL allelesMegan Buckley, Chloé Terwagne, Athina Ganner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2025
Uveal Melanoma UK national guidelines: 2023 updateThomas J Carter, Jack Broadfoot, Sarah E Coupland, et al.
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
European Urology Open Science|June 17, 2026
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141]Leo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Nature Communications|July 15, 2024
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Culliford, Samuel E D Lawrence, Charlie Mills, et al.
European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.
Clinical Genitourinary Cancer|December 28, 2020
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a CureBrian Rini, E Jason Abel, Laurence Albiges, et al.
European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.
European Urology|July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursHolger Moch, Mahul B Amin, Daniel M Berney, et al.
Cancer Discovery|May 2, 2025
MANIFEST: Multiomic Platform for Cancer ImmunotherapyKok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie, et al.
Nature Genetics|July 5, 2024
Saturation genome editing maps the functional spectrum of pathogenic VHL allelesMegan Buckley, Chloé Terwagne, Athina Ganner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2025
Uveal Melanoma UK national guidelines: 2023 updateThomas J Carter, Jack Broadfoot, Sarah E Coupland, et al.
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
European Urology Open Science|June 17, 2026
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141]Leo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
Pageof 13